This site is intended only for healthcare professionals resident in the Republic of Ireland
Menu
Close
Menu
Close
Emerging antimicrobial resistance is a global health and development threat.1 Pfizer is committed to promoting the appropriate use of antibiotics, so that they continue to fight infections when they are needed.2 Our antibacterial portfolio includes products which provide alternative therapeutic options for difficult-to-treat infections such as Methicillin Resistant Staphylococcus Aureus (MRSA) and multidrug-resistant infections that are resistant to traditional antibiotics.3-6
Prescribing Information:
Zavicefta® (Avibactam sodium, ceftazidime pentahydrate)
Zinforo® (ceftaroline fosamil)
Zyvox® (linezolid)
World Health Organisation (2021, November 17). Antimicrobial Resistance. Available at Antimicrobial resistance (who.int). Last accessed September 2023.
Pfizer. Committed to the fight against Antimicrobial Resistance (AMR). Pfizer EU Policy. Available at: https://www.pfizereupolicy.eu/article/committed-fight-against-antimicrobial-resistance-amr. Last accessed September 2023.
Zavicefta. Summary of Product characteristics.
Zinforo. Summary of Product characteristics.
Zyvox. Summary of Product Characteristics.
Tygacil. Summary of Product Characteristics.
Clinical suspicion of haemophilia should be raised for patients with a history of easy bruising, spontaneous, or excessive bleeding following trauma or surgery.1
Haemophilia management involves treating specific haemorrhages, as well as preventing bleed recurrence, limiting complications, and restoring tissue and/or organ function to a pre-bleed state.1
Legal Category: S1A
Further information is available upon request
Adverse events should be reported. Report an adverse event to your national reporting system (HPRA Pharmacovigilance)
Adverse events should also be reported to Pfizer Medical Information on 1800 633 363
Please sign in or register to gain access to information relating to Pfizer medicines and vaccines, medical conditions, patient materials and services.
This site is intended only for healthcare professionals resident in the Republic of Ireland. If you are a member of the public wishing to access information on a specific medicine, please visit https://www.medicines.ie
This website is brought to you by Pfizer Healthcare Ireland, 9 Riverwalk, National Digital Park, Citywest Business Campus, Dublin 24, Ireland. Registered in the Republic of Ireland No. 127002.
Copyright © 2024 Pfizer Limited. All rights reserved.
The information on this site is reserved exclusively for healthcare professionals resident in the Republic of Ireland and contains promotional content.
I confirm that I am a healthcare professional* resident in the Republic of Ireland.
If you select 'No', you will be redirected to Pfizer.ie, where you will be able to access information on Pfizer Healthcare Ireland.
*The IPHA Code definition of a healthcare profressional is a person of any of the following classes: (i) Registered medical practitioners (ii) Registered dentists (iii) Registered pharmacists (iv) Registered nurses
Terms of use
PP-UNP-IRL-0733 . March 2024